Tanshinone IIA Suppresses Glioma Cell Proliferation, Migration and Invasion Both in Vitro and in Vivo Partially Through MiR-16-5p/Talin-1 (TLN1) Axis

Overview

Journal Cancer Manag Res

Publisher Dove Medical Press

Specialty Oncology

Date 2020 Nov 16

PMID 33192091

Citations 10

Authors

Shihao You

Xianghui He

Mei Wang

Lina Mao

Lu Zhang

Affiliations

Soon will be listed here.

Abstract

Background: Tanshinone IIA (TIIA) is one of the active constituents derived from the rhizome of Danshen, a traditional Chinese herbal. Recently, microRNAs (miRNAs) have been suggested to be associated with the anticancer role of TIIA. However, it remains vague of the interaction between miRNAs and TIIA in glioma, a common aggressive brain tumor in humans.

Methods: Expression of miRNA (miR)-16-5p and talin-1 (TLN1) was detected using reverse transcription-quantitative polymerase chain reaction and Western blotting. Cell proliferation, migration and invasion were assessed with cell viability assay, transwell assay, Western blotting, and xenograft tumor experiment. The target binding between miR-16-5p and TLN1 was confirmed by dual-luciferase reporter assay and RNA pull-down assay.

Results: TIIA treatment inhibited cell viability, migration and invasion, and decreased Cyclin D1, matrix metalloproteinase (MMP)-9 and Vimentin expression in glioma T98G and A172 cells both in vitro and in vivo. Thus, TIIA induced anti-glioma role, wherein miR-16-5p was upregulated and TLN1 was downregulated. Moreover, silencing miR-16-5p could abate TIIA-mediated suppression on glioma cell proliferation, migration and invasion in vitro and in vivo. TLN1 overexpression also exerted tumor-promoting effect in TIIA-treated T98G and A172 cells. Mechanically, miR-16-5p could regulate TLN1 expression via target binding, and depleting TLN1 could counteract the inhibitory effect of miR-16-5p knockdown on the curative effect of TIIA in T98G and A172 cells.

Conclusion: TIIA exerted the anti-proliferation, anti-migration and anti-invasion role in glioma cells both in vitro and in vivo partially through regulating miR-16-5p/TLN1 axis.

Citing Articles

The Small Molecules of Plant Origin with Anti-Glioma Activity.

Liu X, Su Y, Yang Y, Li R, Zhang Z Int J Mol Sci. 2025; 26(5).

PMID: 40076568 PMC: 11900624. DOI: 10.3390/ijms26051942.

EMB-driven glioblastoma multiforme progression via the MCT4/GPX3 axis: therapeutic inhibition by Ganxintriol A.

Cheng B, Liu J, Gao L, Zhu Z, Yang Y, Liu S J Transl Med. 2025; 23(1):272.

PMID: 40038742 PMC: 11881305. DOI: 10.1186/s12967-025-06290-z.

TLN1: an oncogene associated with tumorigenesis and progression.

Li S, Chen A, Gui J, Zhou H, Zhu L, Mi Y Discov Oncol. 2024; 15(1):716.

PMID: 39589610 PMC: 11599537. DOI: 10.1007/s12672-024-01593-x.

Nrf2/Keap1/ARE regulation by plant secondary metabolites: a new horizon in brain tumor management.

Dewanjee S, Bhattacharya H, Bhattacharyya C, Chakraborty P, Fleishman J, Alexiou A Cell Commun Signal. 2024; 22(1):497.

PMID: 39407193 PMC: 11476647. DOI: 10.1186/s12964-024-01878-2.

Immunogenic cell death mediated TLR3/4-activated MSCs in U87 GBM cell line.

Meybodi S, Moraddahande F, Dehghani Firoozabadi A Heliyon. 2024; 10(9):e29858.

PMID: 38698968 PMC: 11064142. DOI: 10.1016/j.heliyon.2024.e29858.

References

Yang T, Lu X, Wu T, Ding D, Zhao Z, Chen G . MicroRNA-16 inhibits glioma cell growth and invasion through suppression of BCL2 and the nuclear factor-κB1/MMP9 signaling pathway. Cancer Sci. 2014; 105(3):265-71. PMC: 4317940. DOI: 10.1111/cas.12351. View

DUrso P, DUrso O, Damiano Gianfreda C, Mezzolla V, Storelli C, Marsigliante S . miR-15b and miR-21 as Circulating Biomarkers for Diagnosis of Glioma. Curr Genomics. 2016; 16(5):304-11. PMC: 4763968. DOI: 10.2174/1389202916666150707155610. View

Darefsky A, King Jr J, Dubrow R . Adult glioblastoma multiforme survival in the temozolomide era: a population-based analysis of Surveillance, Epidemiology, and End Results registries. Cancer. 2011; 118(8):2163-72. PMC: 3235223. DOI: 10.1002/cncr.26494. View

Krell A, Wolter M, Stojcheva N, Hertler C, Liesenberg F, Zapatka M . MiR-16-5p is frequently down-regulated in astrocytic gliomas and modulates glioma cell proliferation, apoptosis and response to cytotoxic therapy. Neuropathol Appl Neurobiol. 2018; 45(5):441-458. DOI: 10.1111/nan.12532. View

Xu X, Jiang Q, Ma X, Ying Q, Shen B, Qian Y . Deep sequencing identifies tissue-specific microRNAs and their target genes involving in the biosynthesis of tanshinones in Salvia miltiorrhiza. PLoS One. 2014; 9(11):e111679. PMC: 4218800. DOI: 10.1371/journal.pone.0111679. View

Wang J, Wang X, Jiang S, Yuan S, Lin P, Zhang J . Growth inhibition and induction of apoptosis and differentiation of tanshinone IIA in human glioma cells. J Neurooncol. 2006; 82(1):11-21. DOI: 10.1007/s11060-006-9242-x. View

Han J, Chen Q . MiR-16 modulate temozolomide resistance by regulating BCL-2 in human glioma cells. Int J Clin Exp Pathol. 2016; 8(10):12698-707. PMC: 4680404. View

Zhang Y, Jiang P, Ye M, Kim S, Jiang C, Lu J . Tanshinones: sources, pharmacokinetics and anti-cancer activities. Int J Mol Sci. 2012; 13(10):13621-66. PMC: 3497345. DOI: 10.3390/ijms131013621. View

Ding L, Wang S, Wang W, Lv P, Zhao D, Chen F . Tanshinone IIA Affects Autophagy and Apoptosis of Glioma Cells by Inhibiting Phosphatidylinositol 3-Kinase/Akt/Mammalian Target of Rapamycin Signaling Pathway. Pharmacology. 2016; 99(3-4):188-195. DOI: 10.1159/000452340. View

10.

Tian X, Wu J . Tanshinone derivatives: a patent review (January 2006 - September 2012). Expert Opin Ther Pat. 2012; 23(1):19-29. DOI: 10.1517/13543776.2013.736494. View

11.

Ahir B, Ozer H, Engelhard H, Lakka S . MicroRNAs in glioblastoma pathogenesis and therapy: A comprehensive review. Crit Rev Oncol Hematol. 2017; 120:22-33. DOI: 10.1016/j.critrevonc.2017.10.003. View

12.

Xu S, Liu P . Tanshinone II-A: new perspectives for old remedies. Expert Opin Ther Pat. 2012; 23(2):149-53. DOI: 10.1517/13543776.2013.743995. View

13.

Di Cesare Mannelli L, Piccolo M, Maione F, Ferraro M, Irace C, De Feo V . Tanshinones from Salvia miltiorrhiza Bunge revert chemotherapy-induced neuropathic pain and reduce glioblastoma cells malignancy. Biomed Pharmacother. 2018; 105:1042-1049. DOI: 10.1016/j.biopha.2018.06.047. View

14.

Singel S, Cornelius C, Batten K, Fasciani G, Wright W, Lum L . A targeted RNAi screen of the breast cancer genome identifies KIF14 and TLN1 as genes that modulate docetaxel chemosensitivity in triple-negative breast cancer. Clin Cancer Res. 2013; 19(8):2061-70. PMC: 4513911. DOI: 10.1158/1078-0432.CCR-13-0082. View

15.

Ren X, Wang C, Xie B, Hu L, Chai H, Ding L . Tanshinone IIA induced cell death via miR30b-p53-PTPN11/SHP2 signaling pathway in human hepatocellular carcinoma cells. Eur J Pharmacol. 2016; 796:233-241. DOI: 10.1016/j.ejphar.2016.11.046. View

16.

Sen S, Ng W, Kumar S . Contributions of talin-1 to glioma cell-matrix tensional homeostasis. J R Soc Interface. 2011; 9(71):1311-7. PMC: 3350720. DOI: 10.1098/rsif.2011.0567. View

17.

Chen M, Jenh Y, Wu S, Chen Y, Hanagata N, Lin F . Non-invasive Photodynamic Therapy in Brain Cancer by Use of Tb-Doped LaF Nanoparticles in Combination with Photosensitizer Through X-ray Irradiation: A Proof-of-Concept Study. Nanoscale Res Lett. 2017; 12(1):62. PMC: 5253140. DOI: 10.1186/s11671-017-1840-3. View

18.

Lam B, Lo A, Sun X, Luo H, Chung S, Sucher N . Neuroprotective effects of tanshinones in transient focal cerebral ischemia in mice. Phytomedicine. 2003; 10(4):286-91. DOI: 10.1078/094471103322004776. View

19.

Yang L, Guo H, Dong L, Wang L, Liu C, Wang X . Tanshinone IIA inhibits the growth, attenuates the stemness and induces the apoptosis of human glioma stem cells. Oncol Rep. 2014; 32(3):1303-11. DOI: 10.3892/or.2014.3293. View

20.

Carbonell W, Delay M, Jahangiri A, Park C, Aghi M . β1 integrin targeting potentiates antiangiogenic therapy and inhibits the growth of bevacizumab-resistant glioblastoma. Cancer Res. 2013; 73(10):3145-54. PMC: 4040366. DOI: 10.1158/0008-5472.CAN-13-0011. View